TWOEquity · Weekly research terminal

6620

Handa Pharmaceuticals, Inc.

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
14 Aug 2026
Weekly close
77.40 TWD
Fair value
101.77 TWD
Next-week expectancy
Negative 41.33%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

6620

Handa Pharmaceuticals, Inc.

Healthcare Drug Manufacturers - Specialty & Generic

Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States. The company offers ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; Phyrago, an oral kinase inhibitor used to treat chronic myeloid leukemia and acute lymphoblastic leukemia; Tascenso ODT for the treatment of multiple sclerosis; and HND-033, …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
12,579,736,576
Fair value reference
101.77
Next-week expectancy
Negative · 41.33%

Over the latest 12 completed weeks ending 2026-08-14, 6620 rose 9.72%, moving from 70.54 to 77.40. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -40.66 and has improved across the 12-week window. Market Dynamics is 0.68 on the latest week. Next-week expectancy is negative at 41.33% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
77.40
12-Week Change
9.72%
Trend Signal
Active
Next-Week Expectancy
Negative 41.33%
Signal Weeks
4 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
77.40
12-Week Change
9.72%
Trend Signal
Active
Next-Week Expectancy
Negative 41.33%
Signal Weeks
4 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-40.66
Market Dynamics
0.68

Over the latest 12 completed weeks ending 2026-08-14, 6620 rose 9.72%, moving from 70.54 to 77.40. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 4 of the last 12 weeks. Relative Strength is -40.66 and has improved across the 12-week window. Market Dynamics is 0.68 on the latest week. Next-week expectancy is negative at 41.33% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 14 Aug 2026 1200.00 1550.00 1190.00 1500.00 25.00%
6932 Merdury Biopharmaceutical Corporation TWO 14 Aug 2026 5.13 8.63 5.01 6.02 17.35%
7829 Yoda Pharmaceuticals Inc. TWO 14 Aug 2026 39.85 46.35 39.85 44.90 12.67%
4747 Johnson Chemical Pharmaceutical Works Co., Ltd. TWO 14 Aug 2026 49.70 58.10 49.70 54.50 9.66%
6467 TAHO Pharma TWO 14 Aug 2026 114.00 130.00 114.00 125.00 9.65%
6621 UniPharma Co., Ltd. TWO 14 Aug 2026 11.00 11.95 10.60 11.65 5.91%
6539 DV Biomed Co., Ltd. TWO 14 Aug 2026 40.30 42.40 38.30 42.40 5.21%
4172 InnoPharmax Inc. TWO 14 Aug 2026 10.95 11.45 10.70 11.45 4.57%
1780 Allied Biotech Corporation TWO 14 Aug 2026 22.75 23.75 22.30 23.75 4.40%
6483 Original BioMedicals Co., Ltd. TWO 14 Aug 2026 13.50 14.10 13.50 14.05 4.07%
6785 Alar Pharmaceuticals Inc. TWO 14 Aug 2026 98.10 104.00 96.50 100.00 1.94%
4114 Synmosa Biopharma Corporation TWO 14 Aug 2026 29.30 30.15 29.05 29.80 1.71%
3705 YungShin Global Holding Corporation TAI 14 Aug 2026 53.50 54.50 53.00 54.30 1.50%
7860 TEH SENG TWO 14 Aug 2026 71.20 74.00 68.50 72.00 1.12%
4108 PhytoHealth Corporation TAI 14 Aug 2026 11.15 11.25 10.90 11.25 0.90%
6576 Foresee Pharmaceuticals Co., Ltd. TWO 14 Aug 2026 79.00 80.70 78.70 79.70 0.89%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context